Loading...
BVMF
BALM3
Market cap34mUSD
Nov 13, Last price  
22.50BRL
Name

Baumer SA

Chart & Performance

D1W1MN
BVMF:BALM3 chart
P/E
6.97
P/S
1.13
EPS
3.23
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
5.42%
Revenues
194m
+14.38%
53,936,00065,106,00065,303,00074,055,00085,202,00094,812,00093,512,00099,746,000108,697,000116,297,000112,044,000113,105,000109,754,000119,803,000149,310,000325,946,000267,640,000329,088,000169,950,000194,386,000
Net income
32m
+253.53%
3,382,0005,421,0001,833,0004,215,0001,980,0003,717,0006,933,0008,458,00013,128,00011,497,00014,352,0003,016,000675,0002,753,0004,194,00016,431,00010,132,0005,709,0008,940,00031,606,000
CFO
31m
+22.21%
578,0003,240,000201,0007,075,0001,503,0008,867,0005,034,0004,694,000766,0005,534,000-2,870,00014,527,00026,325,00017,635,0003,133,00025,593,00031,278,000
Dividend
Dec 06, 20230.77647 BRL/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Baumer S.A. develops solutions in hospitals, odontology, and health industry equipment in Brazil, Europe, Asia, and the United States. It offers sterilization and infection control solutions, such as steam sterilizers, formoldehyde and hydrogen peroxide steam sterilizers, solid waste treatment systems, ethylene oxide sterilizers, thermal washer disinfectors, drying cabinets, ultrasonic reprocessors, preparation and storage systems, loading and water treatment systems, test and control, and steam generators. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables; and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as pedicle fixation system, occipitocervial fixation systems, cervical cage angled, and posterior lumbar cages. Further, the company offers dental solutions, including implants and biomaterials. It serves hospitals, clinics, hemocenters, universities, public health service, and carrier health markets; and pharmaceutical, food, and cosmetics industries, as well as research institutes and laboratories. The company was founded in 1952 and is based in Pacaembu, Brazil.
IPO date
Jun 06, 1995
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT